ArticleTheranostics2021

LT-171-861, a novel FLT3 inhibitor, shows excellent preclinical efficacy for the treatment of FLT3 mutant acute myeloid leukemia.

Zhou Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.